Here’s a quick look at what you found most interesting during the past year.
LIBERTY-CUPID Study C Confirms Benefit of Dupilumab in Biologic-Naive CSU
Diabetes Dialogue: Real-World Experience with the Dexcom Stelo
Internet Source Quality Influences Psoriasis Management
Diabetes Dialogue: Lingo Availability and FDA Clearance for Embecta's Tubeless Patch Pump
Nanoscope Reports Positive End-of-Phase 2 Meeting for MCO-010 Gene Therapy
FDA Approves Lebrikizumab Treatment of Eczema Among Patients Aged 12 and Older
